English
简体中文
Total: £ 56.28
Published Date: 2025-08-08 | Pages: 89 | Tables: 88 | Medical Care
The global market for In Vitro Dagnostics for Haemostasis was valued at US$ 3121 million in the year 2024 and is projected to reach a revised size of US$ 5449 million by 2031, growing at a CAGR of 8.3% during the forecast period.
In vitro diagnostics for haemostasis refers to laboratory-based testing conducted outside the human body to evaluate the blood's ability to maintain hemostasis—preventing both excessive bleeding and unwanted clot formation. These tests are performed using blood or plasma samples, and rely on specialized instruments, reagents, and assay protocols. They assess factors such as clotting time, fibrin formation, platelet function, and fibrinolysis. Common tests include Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Thrombin Time (TT), Fibrinogen concentration, D-dimer levels, and advanced assays such as thromboelastography (TEG) and anti-Xa activity. These diagnostics are essential for managing bleeding disorders, thrombotic diseases, surgical risks, and anticoagulant therapy.
In vitro diagnostics for haemostasis has become an essential part of modern laboratory medicine, especially as personalized healthcare and risk stratification gain importance in clinical practice. With the growing complexity of patient care—ranging from cardiovascular surgery and oncology treatment to chronic disease management—the need for precise, efficient, and reliable coagulation testing is steadily increasing. Hospitals and diagnostic laboratories are investing in automated coagulation analyzers and comprehensive reagent systems to handle routine and specialized testing with high accuracy and low turnaround time. These systems are often integrated into broader laboratory automation platforms to streamline workflow and improve result consistency.
In the Chinese medical context, the application of haemostasis IVD has expanded rapidly, driven by the increased prevalence of thrombosis-related conditions and the widespread use of anticoagulant drugs in both outpatient and inpatient settings. From tertiary hospitals to regional healthcare facilities, the emphasis on early diagnosis, perioperative safety, and treatment monitoring has made haemostasis diagnostics a standard component of clinical decision-making. Additionally, the development of domestic brands and reagent systems has lowered testing costs and improved access to advanced diagnostics in lower-tier cities and rural hospitals. Beyond traditional clotting tests, demand for personalized profiles—such as TEG, platelet mapping, and global coagulation assays—is gradually rising, reflecting the shift toward more dynamic, patient-specific diagnostics. As clinical pathways evolve, haemostasis IVD will play an increasingly central role in improving patient safety and treatment outcomes.
This report aims to provide a comprehensive presentation of the global market for In Vitro Dagnostics for Haemostasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Dagnostics for Haemostasis.
The In Vitro Dagnostics for Haemostasis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Dagnostics for Haemostasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Dagnostics for Haemostasis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sysmex
Stago
Werfen
Sekisui Medical
Behnk Elektronik (BE)
Roche
Thermo Fischer
Beijing Succeeder Technology
Mindray Medical
Shanghai Sun Biotechnology
Rayto Life and Analytical Sciences
Beijing ZONCI Technology Development
Shenzhen Dymind Biotechnology
TECO
ACCURDX
Segment by Type
Diagnostic Equipment
Diagnostic Reagents
Segment by Application
Hospital
Research Institutions
Diagnostic Centers
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Dagnostics for Haemostasis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Dagnostics for Haemostasis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Equipment
1.2.3 Diagnostic Reagents
1.3 Market by Application
1.3.1 Global In Vitro Dagnostics for Haemostasis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Diagnostic Centers
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Dagnostics for Haemostasis Market Perspective (2020-2031)
2.2 Global In Vitro Dagnostics for Haemostasis Growth Trends by Region
2.2.1 Global In Vitro Dagnostics for Haemostasis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vitro Dagnostics for Haemostasis Historic Market Size by Region (2020-2025)
2.2.3 In Vitro Dagnostics for Haemostasis Forecasted Market Size by Region (2026-2031)
2.3 In Vitro Dagnostics for Haemostasis Market Dynamics
2.3.1 In Vitro Dagnostics for Haemostasis Industry Trends
2.3.2 In Vitro Dagnostics for Haemostasis Market Drivers
2.3.3 In Vitro Dagnostics for Haemostasis Market Challenges
2.3.4 In Vitro Dagnostics for Haemostasis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Dagnostics for Haemostasis Players by Revenue
3.1.1 Global Top In Vitro Dagnostics for Haemostasis Players by Revenue (2020-2025)
3.1.2 Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Players (2020-2025)
3.2 Global Top In Vitro Dagnostics for Haemostasis Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vitro Dagnostics for Haemostasis Revenue
3.4 Global In Vitro Dagnostics for Haemostasis Market Concentration Ratio
3.4.1 Global In Vitro Dagnostics for Haemostasis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Dagnostics for Haemostasis Revenue in 2024
3.5 Global Key Players of In Vitro Dagnostics for Haemostasis Head office and Area Served
3.6 Global Key Players of In Vitro Dagnostics for Haemostasis, Product and Application
3.7 Global Key Players of In Vitro Dagnostics for Haemostasis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Dagnostics for Haemostasis Breakdown Data by Type
4.1 Global In Vitro Dagnostics for Haemostasis Historic Market Size by Type (2020-2025)
4.2 Global In Vitro Dagnostics for Haemostasis Forecasted Market Size by Type (2026-2031)
5 In Vitro Dagnostics for Haemostasis Breakdown Data by Application
5.1 Global In Vitro Dagnostics for Haemostasis Historic Market Size by Application (2020-2025)
5.2 Global In Vitro Dagnostics for Haemostasis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vitro Dagnostics for Haemostasis Market Size (2020-2031)
6.2 North America In Vitro Dagnostics for Haemostasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vitro Dagnostics for Haemostasis Market Size by Country (2020-2025)
6.4 North America In Vitro Dagnostics for Haemostasis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Dagnostics for Haemostasis Market Size (2020-2031)
7.2 Europe In Vitro Dagnostics for Haemostasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vitro Dagnostics for Haemostasis Market Size by Country (2020-2025)
7.4 Europe In Vitro Dagnostics for Haemostasis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Dagnostics for Haemostasis Market Size (2020-2031)
8.2 Asia-Pacific In Vitro Dagnostics for Haemostasis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vitro Dagnostics for Haemostasis Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vitro Dagnostics for Haemostasis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America In Vitro Dagnostics for Haemostasis Market Size (2020-2031)
9.2 Latin America In Vitro Dagnostics for Haemostasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vitro Dagnostics for Haemostasis Market Size by Country (2020-2025)
9.4 Latin America In Vitro Dagnostics for Haemostasis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size (2020-2031)
10.2 Middle East & Africa In Vitro Dagnostics for Haemostasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sysmex
11.1.1 Sysmex Company Details
11.1.2 Sysmex Business Overview
11.1.3 Sysmex In Vitro Dagnostics for Haemostasis Introduction
11.1.4 Sysmex Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.1.5 Sysmex Recent Development
11.2 Stago
11.2.1 Stago Company Details
11.2.2 Stago Business Overview
11.2.3 Stago In Vitro Dagnostics for Haemostasis Introduction
11.2.4 Stago Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.2.5 Stago Recent Development
11.3 Werfen
11.3.1 Werfen Company Details
11.3.2 Werfen Business Overview
11.3.3 Werfen In Vitro Dagnostics for Haemostasis Introduction
11.3.4 Werfen Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.3.5 Werfen Recent Development
11.4 Sekisui Medical
11.4.1 Sekisui Medical Company Details
11.4.2 Sekisui Medical Business Overview
11.4.3 Sekisui Medical In Vitro Dagnostics for Haemostasis Introduction
11.4.4 Sekisui Medical Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.4.5 Sekisui Medical Recent Development
11.5 Behnk Elektronik (BE)
11.5.1 Behnk Elektronik (BE) Company Details
11.5.2 Behnk Elektronik (BE) Business Overview
11.5.3 Behnk Elektronik (BE) In Vitro Dagnostics for Haemostasis Introduction
11.5.4 Behnk Elektronik (BE) Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.5.5 Behnk Elektronik (BE) Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche In Vitro Dagnostics for Haemostasis Introduction
11.6.4 Roche Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Thermo Fischer
11.7.1 Thermo Fischer Company Details
11.7.2 Thermo Fischer Business Overview
11.7.3 Thermo Fischer In Vitro Dagnostics for Haemostasis Introduction
11.7.4 Thermo Fischer Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.7.5 Thermo Fischer Recent Development
11.8 Beijing Succeeder Technology
11.8.1 Beijing Succeeder Technology Company Details
11.8.2 Beijing Succeeder Technology Business Overview
11.8.3 Beijing Succeeder Technology In Vitro Dagnostics for Haemostasis Introduction
11.8.4 Beijing Succeeder Technology Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.8.5 Beijing Succeeder Technology Recent Development
11.9 Mindray Medical
11.9.1 Mindray Medical Company Details
11.9.2 Mindray Medical Business Overview
11.9.3 Mindray Medical In Vitro Dagnostics for Haemostasis Introduction
11.9.4 Mindray Medical Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.9.5 Mindray Medical Recent Development
11.10 Shanghai Sun Biotechnology
11.10.1 Shanghai Sun Biotechnology Company Details
11.10.2 Shanghai Sun Biotechnology Business Overview
11.10.3 Shanghai Sun Biotechnology In Vitro Dagnostics for Haemostasis Introduction
11.10.4 Shanghai Sun Biotechnology Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.10.5 Shanghai Sun Biotechnology Recent Development
11.11 Rayto Life and Analytical Sciences
11.11.1 Rayto Life and Analytical Sciences Company Details
11.11.2 Rayto Life and Analytical Sciences Business Overview
11.11.3 Rayto Life and Analytical Sciences In Vitro Dagnostics for Haemostasis Introduction
11.11.4 Rayto Life and Analytical Sciences Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.11.5 Rayto Life and Analytical Sciences Recent Development
11.12 Beijing ZONCI Technology Development
11.12.1 Beijing ZONCI Technology Development Company Details
11.12.2 Beijing ZONCI Technology Development Business Overview
11.12.3 Beijing ZONCI Technology Development In Vitro Dagnostics for Haemostasis Introduction
11.12.4 Beijing ZONCI Technology Development Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.12.5 Beijing ZONCI Technology Development Recent Development
11.13 Shenzhen Dymind Biotechnology
11.13.1 Shenzhen Dymind Biotechnology Company Details
11.13.2 Shenzhen Dymind Biotechnology Business Overview
11.13.3 Shenzhen Dymind Biotechnology In Vitro Dagnostics for Haemostasis Introduction
11.13.4 Shenzhen Dymind Biotechnology Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.13.5 Shenzhen Dymind Biotechnology Recent Development
11.14 TECO
11.14.1 TECO Company Details
11.14.2 TECO Business Overview
11.14.3 TECO In Vitro Dagnostics for Haemostasis Introduction
11.14.4 TECO Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.14.5 TECO Recent Development
11.15 ACCURDX
11.15.1 ACCURDX Company Details
11.15.2 ACCURDX Business Overview
11.15.3 ACCURDX In Vitro Dagnostics for Haemostasis Introduction
11.15.4 ACCURDX Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025)
11.15.5 ACCURDX Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global In Vitro Dagnostics for Haemostasis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostic Equipment
Table 3. Key Players of Diagnostic Reagents
Table 4. Global In Vitro Dagnostics for Haemostasis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global In Vitro Dagnostics for Haemostasis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global In Vitro Dagnostics for Haemostasis Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global In Vitro Dagnostics for Haemostasis Market Share by Region (2020-2025)
Table 8. Global In Vitro Dagnostics for Haemostasis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global In Vitro Dagnostics for Haemostasis Market Share by Region (2026-2031)
Table 10. In Vitro Dagnostics for Haemostasis Market Trends
Table 11. In Vitro Dagnostics for Haemostasis Market Drivers
Table 12. In Vitro Dagnostics for Haemostasis Market Challenges
Table 13. In Vitro Dagnostics for Haemostasis Market Restraints
Table 14. Global In Vitro Dagnostics for Haemostasis Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global In Vitro Dagnostics for Haemostasis Market Share by Players (2020-2025)
Table 16. Global Top In Vitro Dagnostics for Haemostasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Dagnostics for Haemostasis as of 2024)
Table 17. Ranking of Global Top In Vitro Dagnostics for Haemostasis Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by In Vitro Dagnostics for Haemostasis Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of In Vitro Dagnostics for Haemostasis, Headquarters and Area Served
Table 20. Global Key Players of In Vitro Dagnostics for Haemostasis, Product and Application
Table 21. Global Key Players of In Vitro Dagnostics for Haemostasis, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In Vitro Dagnostics for Haemostasis Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Type (2020-2025)
Table 25. Global In Vitro Dagnostics for Haemostasis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Type (2026-2031)
Table 27. Global In Vitro Dagnostics for Haemostasis Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Application (2020-2025)
Table 29. Global In Vitro Dagnostics for Haemostasis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Application (2026-2031)
Table 31. North America In Vitro Dagnostics for Haemostasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America In Vitro Dagnostics for Haemostasis Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America In Vitro Dagnostics for Haemostasis Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe In Vitro Dagnostics for Haemostasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe In Vitro Dagnostics for Haemostasis Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe In Vitro Dagnostics for Haemostasis Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific In Vitro Dagnostics for Haemostasis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific In Vitro Dagnostics for Haemostasis Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific In Vitro Dagnostics for Haemostasis Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America In Vitro Dagnostics for Haemostasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America In Vitro Dagnostics for Haemostasis Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America In Vitro Dagnostics for Haemostasis Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Country (2026-2031) & (US$ Million)
Table 46. Sysmex Company Details
Table 47. Sysmex Business Overview
Table 48. Sysmex In Vitro Dagnostics for Haemostasis Product
Table 49. Sysmex Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 50. Sysmex Recent Development
Table 51. Stago Company Details
Table 52. Stago Business Overview
Table 53. Stago In Vitro Dagnostics for Haemostasis Product
Table 54. Stago Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 55. Stago Recent Development
Table 56. Werfen Company Details
Table 57. Werfen Business Overview
Table 58. Werfen In Vitro Dagnostics for Haemostasis Product
Table 59. Werfen Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 60. Werfen Recent Development
Table 61. Sekisui Medical Company Details
Table 62. Sekisui Medical Business Overview
Table 63. Sekisui Medical In Vitro Dagnostics for Haemostasis Product
Table 64. Sekisui Medical Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 65. Sekisui Medical Recent Development
Table 66. Behnk Elektronik (BE) Company Details
Table 67. Behnk Elektronik (BE) Business Overview
Table 68. Behnk Elektronik (BE) In Vitro Dagnostics for Haemostasis Product
Table 69. Behnk Elektronik (BE) Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 70. Behnk Elektronik (BE) Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche In Vitro Dagnostics for Haemostasis Product
Table 74. Roche Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Thermo Fischer Company Details
Table 77. Thermo Fischer Business Overview
Table 78. Thermo Fischer In Vitro Dagnostics for Haemostasis Product
Table 79. Thermo Fischer Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 80. Thermo Fischer Recent Development
Table 81. Beijing Succeeder Technology Company Details
Table 82. Beijing Succeeder Technology Business Overview
Table 83. Beijing Succeeder Technology In Vitro Dagnostics for Haemostasis Product
Table 84. Beijing Succeeder Technology Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 85. Beijing Succeeder Technology Recent Development
Table 86. Mindray Medical Company Details
Table 87. Mindray Medical Business Overview
Table 88. Mindray Medical In Vitro Dagnostics for Haemostasis Product
Table 89. Mindray Medical Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 90. Mindray Medical Recent Development
Table 91. Shanghai Sun Biotechnology Company Details
Table 92. Shanghai Sun Biotechnology Business Overview
Table 93. Shanghai Sun Biotechnology In Vitro Dagnostics for Haemostasis Product
Table 94. Shanghai Sun Biotechnology Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 95. Shanghai Sun Biotechnology Recent Development
Table 96. Rayto Life and Analytical Sciences Company Details
Table 97. Rayto Life and Analytical Sciences Business Overview
Table 98. Rayto Life and Analytical Sciences In Vitro Dagnostics for Haemostasis Product
Table 99. Rayto Life and Analytical Sciences Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 100. Rayto Life and Analytical Sciences Recent Development
Table 101. Beijing ZONCI Technology Development Company Details
Table 102. Beijing ZONCI Technology Development Business Overview
Table 103. Beijing ZONCI Technology Development In Vitro Dagnostics for Haemostasis Product
Table 104. Beijing ZONCI Technology Development Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 105. Beijing ZONCI Technology Development Recent Development
Table 106. Shenzhen Dymind Biotechnology Company Details
Table 107. Shenzhen Dymind Biotechnology Business Overview
Table 108. Shenzhen Dymind Biotechnology In Vitro Dagnostics for Haemostasis Product
Table 109. Shenzhen Dymind Biotechnology Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 110. Shenzhen Dymind Biotechnology Recent Development
Table 111. TECO Company Details
Table 112. TECO Business Overview
Table 113. TECO In Vitro Dagnostics for Haemostasis Product
Table 114. TECO Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 115. TECO Recent Development
Table 116. ACCURDX Company Details
Table 117. ACCURDX Business Overview
Table 118. ACCURDX In Vitro Dagnostics for Haemostasis Product
Table 119. ACCURDX Revenue in In Vitro Dagnostics for Haemostasis Business (2020-2025) & (US$ Million)
Table 120. ACCURDX Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. In Vitro Dagnostics for Haemostasis Picture
Figure 2. Global In Vitro Dagnostics for Haemostasis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In Vitro Dagnostics for Haemostasis Market Share by Type: 2024 VS 2031
Figure 4. Diagnostic Equipment Features
Figure 5. Diagnostic Reagents Features
Figure 6. Global In Vitro Dagnostics for Haemostasis Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global In Vitro Dagnostics for Haemostasis Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Research Institutions Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Other Case Studies
Figure 12. In Vitro Dagnostics for Haemostasis Report Years Considered
Figure 13. Global In Vitro Dagnostics for Haemostasis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global In Vitro Dagnostics for Haemostasis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global In Vitro Dagnostics for Haemostasis Market Share by Region: 2024 VS 2031
Figure 16. Global In Vitro Dagnostics for Haemostasis Market Share by Players in 2024
Figure 17. Global In Vitro Dagnostics for Haemostasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by In Vitro Dagnostics for Haemostasis Revenue in 2024
Figure 19. North America In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America In Vitro Dagnostics for Haemostasis Market Share by Country (2020-2031)
Figure 21. United States In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe In Vitro Dagnostics for Haemostasis Market Share by Country (2020-2031)
Figure 25. Germany In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific In Vitro Dagnostics for Haemostasis Market Share by Region (2020-2031)
Figure 33. China In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America In Vitro Dagnostics for Haemostasis Market Share by Country (2020-2031)
Figure 41. Mexico In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Share by Country (2020-2031)
Figure 45. Israel In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE In Vitro Dagnostics for Haemostasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Sysmex Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 49. Stago Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 50. Werfen Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 51. Sekisui Medical Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 52. Behnk Elektronik (BE) Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 53. Roche Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 54. Thermo Fischer Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 55. Beijing Succeeder Technology Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 56. Mindray Medical Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 57. Shanghai Sun Biotechnology Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 58. Rayto Life and Analytical Sciences Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 59. Beijing ZONCI Technology Development Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 60. Shenzhen Dymind Biotechnology Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 61. TECO Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 62. ACCURDX Revenue Growth Rate in In Vitro Dagnostics for Haemostasis Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
